Rentschler Biopharma to produce 100m doses of CureVac vaccine

"German CDMO Rentschler Biopharma is expanding cCMP production of CureVac NV’s RNA-based COVID-19 vaccine candidate CVnCoV...."
020321 Rentschler Biopharma to produce 1
.
Download • 503KB